Author

J Vachiéry

Observed name: J.L. Vachiéry

Institutions: Université Libre de Bruxelles, Erasmus Hospital

Observed institutions: University of Bergamo, Université Libre de Bruxelles, Erasmus Hospital, Ospedale Papa Giovanni XXIII, IRCCS Istituto Auxologico Italiano

OpenAlex ID: A5070599187

Right ventricular reserve in cardiopulmonary disease: A simultaneous hemodynamic and three-dimensional echocardiographic study

2024 · C. Baratto, C. Dewachter, et al. · The Journal of Heart and Lung Transplantation · 5

Interim Results from the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH)

2025 · H Ghofrani, S Sahay, et al. · Pneumologie

Trial in Progress: PROSERA, a Phase 3 Study of the Efficacy and Safety of Seralutinib in Adults with Pulmonary Arterial Hypertension (PAH)

2025 · M Held, O Sitbon, et al. · Pneumologie

TORREY Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension (PAH): Circulating Biomarkers of Proliferation, Inflammation and Fibrosis Improve with Treatment

2025 · H Ghofrani, R Osterhout, et al. · Pneumologie

P231 Pulmonary Artery Wedge Pressure Vs Left Ventricular End–diastolic Pressure During Exercise in Patients With Unexplained Dyspnea

2022 · S Caravita, C Baratto, et al. · European Heart Journal Supplements

P284 the Right Heart Adaptats to Exercise More Efficiently in Pulmonary Arterial Hypertension Than in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction

2022 · C Baratto, S Caravita, et al. · European Heart Journal Supplements

Works count: 6

Citation count: 5

H-index: 1

I10-index: